BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Universal Display Corporation Announces Fourth Quarter and Fiscal Year 2024 Conference Call

  January 27, 2025

   · 

  3 min read
• Press Releases

  Theralase(R) Interim Clinical Data to be Presented at the 2025 AUA Annual Meeting

  January 27, 2025

   · 

  7 min read
• Press Releases

  Bio-Rad to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025

  January 27, 2025

   · 

  1 min read
• Press Releases

  Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

  January 27, 2025

   · 

  5 min read
• Press Releases

  ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more endocrine therapies

  January 27, 2025

   · 

  19 min read
• 

  Press Releases

  Bone and Joint Infection Market Size to Reach USD 129.9 Million by 2035, Impelled by Advancements in Personalized and Targeted Treatments

  January 27, 2025

   · 

  12 min read
• Press Releases

  NMDP Strengthens Executive Leadership Team

  January 27, 2025

   · 

  2 min read
• Press Releases

  Apellis Receives Approval of SYFOVRE® (pegcetacoplan) in Australia for Geographic Atrophy (GA)

  January 27, 2025

   · 

  3 min read
• Press Releases

  Telix Completes Acquisition of RLS (USA) Inc.

  January 27, 2025

   · 

  8 min read
• Press Releases

  Evolent To Release Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025

  January 27, 2025

   · 

  1 min read